These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16234568)

  • 1. Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains.
    Dilda PJ; Don AS; Tanabe KM; Higgins VJ; Allen JD; Dawes IW; Hogg PJ
    J Natl Cancer Inst; 2005 Oct; 97(20):1539-47. PubMed ID: 16234568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity.
    Dilda PJ; Decollogne S; Rossiter-Thornton M; Hogg PJ
    Cancer Res; 2005 Dec; 65(24):11729-34. PubMed ID: 16357185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
    Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
    Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acid.
    Dilda PJ; Ramsay EE; Corti A; Pompella A; Hogg PJ
    J Biol Chem; 2008 Dec; 283(51):35428-34. PubMed ID: 18723877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodies.
    Cadd VA; Hogg PJ; Harris AL; Feller SM
    BMC Cancer; 2006 Jun; 6():155. PubMed ID: 16764713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
    Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloid.
    Dilda PJ; Perrone GG; Philp A; Lock RB; Dawes IW; Hogg PJ
    Int J Biochem Cell Biol; 2008; 40(5):1016-29. PubMed ID: 18160327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.
    Horsley L; Cummings J; Middleton M; Ward T; Backen A; Clamp A; Dawson M; Farmer H; Fisher N; Halbert G; Halford S; Harris A; Hasan J; Hogg P; Kumaran G; Little R; Parker GJ; Potter P; Saunders M; Roberts C; Shaw D; Smith N; Smythe J; Taylor A; Turner H; Watson Y; Dive C; Jayson GC;
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1343-52. PubMed ID: 24141375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
    Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
    Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.
    Paumi CM; Wright M; Townsend AJ; Morrow CS
    Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
    van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
    Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
    Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
    de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
    Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.
    Stöckel B; König J; Nies AT; Cui Y; Brom M; Keppler D
    Eur J Biochem; 2000 Mar; 267(5):1347-58. PubMed ID: 10691972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of closely spaced protein thiols on the surface of mammalian cells.
    Donoghue N; Yam PT; Jiang XM; Hogg PJ
    Protein Sci; 2000 Dec; 9(12):2436-45. PubMed ID: 11206065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells.
    Don AS; Kisker O; Dilda P; Donoghue N; Zhao X; Decollogne S; Creighton B; Flynn E; Folkman J; Hogg PJ
    Cancer Cell; 2003 May; 3(5):497-509. PubMed ID: 12781367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH; Kuo ML; Chen JC; Chen YC
    Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine enhances multidrug resistance-associated protein 1 mediated doxorubicin resistance.
    Akan I; Akan S; Akca H; Savas B; Ozben T
    Eur J Clin Invest; 2004 Oct; 34(10):683-9. PubMed ID: 15473893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy.
    Cao J; Stieger B; Meier PJ; Vore M
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G757-66. PubMed ID: 12181192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T; Urasaki Y; Takemura H; Ueda T
    Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.